The heart metabolism: pathophysiological aspects in ischaemia and heart failure

Abozguia, K, Shivu, G Nallur, Ahmed, I, Phan, T T and Frenneaux, M P (2009) The heart metabolism: pathophysiological aspects in ischaemia and heart failure. Current Pharmaceutical Design, 15 (8). pp. 827-835. ISSN 1381-6128

Full text not available from this repository.


The morbidity and mortality of coronary heart disease and of heart failure remain unacceptably high despite major advances in their management. The main focus of treatment has been revascularisation for ischaemic heart disease and neuro-humoral modification for heart failure. There is an urgent need for new modalities of treatment to improve mortality and morbidity. Recently, there has been a great deal of interest in the role of disturbances in cardiac energetics and myocardial metabolism in the pathophysiology of both ischaemic heart disease and heart failure and of therapeutic potential of metabolic modulation. The myocardium is a metabolic omnivore, but mainly uses fatty acids and glucose for generation of Adenosine-5'-triphosphate (ATP). This review focuses on the key changes that occur to the metabolism of the heart in ischaemia and in heart failure and its effects on cardiac energetics.

Item Type: Article
Uncontrolled Keywords: adenosine triphosphate,carnitine o-palmitoyltransferase,energy metabolism,fatty acids, nonesterified,glucose,heart failure,humans,myocardial ischemia,myocardium,oxygen consumption,vasodilator agents
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User: Pure Connector
Date Deposited: 13 Mar 2015 16:46
Last Modified: 22 Apr 2023 22:31
DOI: 10.2174/138161209787582101

Actions (login required)

View Item View Item